TVTX - Travere Therapeutics gains as EU backs kidney disease therapy
2024-02-23 07:05:14 ET
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q4 2023 Earnings Call Transcript
- Travere Therapeutics: Restructuring Away From Disaster
- Travere Therapeutics Q4 2023 Earnings Preview
- Travere inks licensing deal for sparsentan in Asia
- Seeking Alpha’s Quant Rating on Travere Therapeutics